Abstract
High plasma levels of lipids are an important modifiable risk factor for coronary heart disease, but are not established as a risk factor for stroke. Pathophysiologic evidence that links lipids to major systemic artery disease, and the results of clinical trials of coronary heart disease prevention in relation to lipid-lowering suggest that lipids may play an important role in the causation of stroke. We discuss the controversy concerning plasma lipids as a risk factor for stroke. A clinical trial targeted at lowering levels of lipids with the aim of primary stroke prevention would be a timely and important contribution. Armed with this information, we could further clarify the plasma lipid-stroke controversy and move into the 21st century with a better understanding of stroke prevention.
Original language | English (US) |
---|---|
Pages (from-to) | 217-221 |
Number of pages | 5 |
Journal | Journal of Cardiovascular Risk |
Volume | 6 |
Issue number | 4 |
DOIs | |
State | Published - 1999 |
Keywords
- Cholesterol
- Hyperlipidemia
- Lipids
- Stroke
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine